Patents Assigned to Hitachi Chemical Co.
  • Patent number: 10697001
    Abstract: Provided herein are devices and methods for the capture or isolation of a biomarker from a biological sample. In several embodiments, the device comprises a loading region, a filter material, and a receiving region. In particular, in several embodiments, biological fluid is passed from the loading region through the filter material and into the receiving region, thereby resulting in capture or isolation of a biomarker.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: June 30, 2020
    Assignees: HITACHI CHEMICAL CO., LTD., HITACHI CHEMICAL CO. AMERICA, LTD.
    Inventors: Masato Mitsuhashi, Taku Murakami
  • Patent number: 10696851
    Abstract: Intercalation pastes for use with semiconductor devices are disclosed. The pastes contain precious metal particles, intercalating particles, and an organic vehicle and can be used to improve the material properties of metal particle layers. Specific formulations have been developed to be screen-printed directly onto a dried metal particle layer and fired to make a fired multilayer stack. The fired multilayer stack can be tailored to create a solderable surface, high mechanical strength, and low contact resistance. In some embodiments, the fired multilayer stack can etch through a dielectric layer to improve adhesion to a substrate. Such pastes can be used to increase the efficiency of silicon solar cells, specifically multi- and mono-crystalline silicon back-surface field (BSF), and passivated emitter and rear contact (PERC) photovoltaic cells. Other applications include integrated circuits and more broadly, electronic devices.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: June 30, 2020
    Assignee: Hitachi Chemical Co., Ltd.
    Inventors: Brian E. Hardin, Erik Sauar, Dhea Suseno, Jesse J. Hinricher, Jennifer Huang, Tom Yu-Tang Lin, Stephen T. Connor, Daniel J. Hellebusch, Craig H. Peters
  • Patent number: 10597480
    Abstract: A laminate film comprising a substrate film and a cured film that is a cured curable composition disposed on one surface or both surfaces of the substrate film is disclosed. The substrate film is a film containing a cyclic olefin resin, and the curable resin composition comprises: (A) an acrylic resin having a polymerizable double bond; (B) a multifunctional polymerizable compound having three or more polymerizable double bonds, and having one or more monovalent groups represented by the following formula (2-1) or (2-2) as a group containing the polymerizable double bond; and (C) an alkylene oxide modified bisphenol A di(meth)acrylate.
    Type: Grant
    Filed: July 16, 2015
    Date of Patent: March 24, 2020
    Assignees: Hitachi Chemical Co., Ltd., Zeon Corporation
    Inventors: Shigeru Kurimoto, Hidekazu Kondou, Kazuo Aizu, Yasunori Ii
  • Publication number: 20200047096
    Abstract: The disclosure relates to filtering devices, capture devices and their uses to isolate nucleic acids from exosome and/or vesicles.
    Type: Application
    Filed: March 9, 2018
    Publication date: February 13, 2020
    Applicants: Hitachi Chemical Co., Ltd., Hitachi Chemical Co. America, Ltd.
    Inventor: Mieko Ogura
  • Patent number: 10550291
    Abstract: Oxidation-resistant electrically-conductive metal particles (ORCMP) are disclosed. ORCMPs are comprised of a base-metal core, an oxidation-resistant first shell, and an optional conductive second shell. ORCMPs are low cost alternatives to silver particles in metal fillers for low-temperature, electrically-conductive adhesives. Adhesives including ORCMPs, organic vehicles, and optional conductive metal particles such as silver were formulated to yield conductive films upon curing at low temperatures. Such films can be used in many electronic devices where low-temperature, low cost films are needed.
    Type: Grant
    Filed: August 22, 2016
    Date of Patent: February 4, 2020
    Assignee: Hitachi Chemical Co., Ltd.
    Inventors: Brian E. Hardin, Stephen T. Connor, Craig H. Peters
  • Patent number: 10542745
    Abstract: Disclosed are methods, device kits, and systems for improved quantification of mRNA from whole blood. More particularly, the devices and kites related thereto are useful for the controlled and repeatable ex vivo stimulation of whole blood.
    Type: Grant
    Filed: October 31, 2011
    Date of Patent: January 28, 2020
    Assignees: Hitachi Chemical Co., Ltd., Hitachi Chemical Company America, Ltd.
    Inventors: Masato Mitsuhashi, Taku Murakami
  • Patent number: 10418497
    Abstract: Metallization pastes for use with semiconductor devices are disclosed. The pastes contain silver particles, low-melting-point base-metal particles, organic vehicle, and optional crystallizing agents. Specific formulations have been developed that produce stratified metal films that contain less silver than conventional pastes and that have high peel strengths. Such pastes can be used to make high contact resistance metallization layers on silicon.
    Type: Grant
    Filed: August 22, 2016
    Date of Patent: September 17, 2019
    Assignee: Hitachi Chemical Co., Ltd.
    Inventors: Brian E. Hardin, Stephen T. Connor, James Randy Groves, Craig H. Peters
  • Patent number: 10370719
    Abstract: The present disclosure relates to methods of collecting exosomes and microvesicles (EMV) from urine and isolating corresponding mRNA in order to diagnose and treat acute kidney injury (AKI). In particular, certain embodiments relate to the method of capturing EMV from urine applied to a filter device that is capable of capturing EMV. Nucleic acids such as mRNA can be isolated from the EMV using an oligo(dT)-coated plate designed to accommodate the filter device and then used for further molecular analysis. Quantification of the collected nucleic acids may then be used in the diagnosis and/or treatment of IBD.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: August 6, 2019
    Assignees: Hitachi Chemical Co., Ltd., Hitachi Chemical Co. America, Ltd., The Regents of the University of California
    Inventors: Satish P. RamachandraRao, Ravindra Lall Mehta, Masato Mitsuhashi, Taku Murakami
  • Patent number: 10266895
    Abstract: The present disclosure relates to methods of collecting intestinal luminal fluid (ILF) exosomes and microvesicles (EMV) and isolating corresponding mRNA in order to diagnose and treat inflammatory bowel diseases (IBD). In particular, certain embodiments relate to the method of capturing EMV from ILF applied to a filter device that is capable of capturing EMV. Nucleic acids such as mRNA can be isolated from the EMV using an oligo(dT)-coated plate designed to accommodate the filter device and then used for further molecular analysis. Quantification of the collected nucleic acids may then be used in the diagnosis and/or treatment of IBD.
    Type: Grant
    Filed: November 3, 2015
    Date of Patent: April 23, 2019
    Assignees: Hitachi Chemical Company Ltd., Hitachi Chemical Co. America, Ltd., Beth Israel Deaconess Medical Center
    Inventors: Masato Mitsuhashi, Alan C. Moss
  • Patent number: 9790542
    Abstract: Some embodiments provide for a device that collects vesicles and vesicle-like materials from biological fluids. Such devices include at least one sample loading region; at least one corresponding vesicle-capture material, wherein said vesicle-capture material includes glass-like materials; and at least one corresponding sample receiving region, wherein passage of the biological fluid from the sample loading region through the vesicle-capture material and into the sample receiving region results in the capture of vesicles. Additional embodiments provide for a method of isolating vesicles and vesicle-like materials from biological fluids.
    Type: Grant
    Filed: January 7, 2015
    Date of Patent: October 17, 2017
    Assignees: HITACHI CHEMICAL CO., LTD., HITACHI CHEMICAL COMPANY AMERICA, LTD.
    Inventor: Masato Mitsuhashi
  • Patent number: 9758826
    Abstract: p53-upregulated modulator of apoptosis (PUMA) is a biomarker associated with islet cell health. If PUMA is low, islet cells are typically healthy. If PUMA is high, islet cells are typically unhealthy or dying. PUMA may be measured by either measuring its nucleic or amino acid. PUMA mRNA may be induced by TNF-? stimulation in a time- and dose-dependent manner and ? cell apoptosis is induced through a mitochondrial pathway. TNF-? significantly inhibited glucose-induced preproinsulin precursor mRNA synthesis. Such ? cell stress signaling in human islets indicates overall state of islet health and, ultimately, the risk of onset and/or degree of severity of both type 1 and type 2 diabetes mellitus.
    Type: Grant
    Filed: June 17, 2011
    Date of Patent: September 12, 2017
    Assignees: City of Hope, Hitachi Chemical Research Center, Inc., Hitachi Chemical Co., Ltd.
    Inventors: Yoko Mullen, Masato Mitsuhashi, Keiko Omori
  • Patent number: 9719129
    Abstract: Provided is a device that collects vesicles and vesicle-like materials from biological fluids. Such devices comprise at least one sample loading region; at least one corresponding vesicle-capture material, wherein said vesicle-capture material comprises glass-like materials; and at least one corresponding sample receiving region, wherein passage of the biological fluid from the sample loading region through the vesicle capture material and into the sample receiving region results in the capture of vesicles. Additional methods provide for a method of isolating vesicles and vesicle-like materials from biological fluids are also provided.
    Type: Grant
    Filed: June 10, 2011
    Date of Patent: August 1, 2017
    Assignees: HITACHI CHEMICAL CO., LTD., HITACHI CHEMICAL COMPANY AMERICA, LTD.
    Inventor: Masato Mitsuhashi
  • Patent number: 9670090
    Abstract: An Ag2O—V2O5—TeO2 lead-free low-melting glass composition that is prevented or restrained from crystallization by heating so as to soften and flow more satisfactorily at a low temperature contains a principal component which includes a vanadium oxide, a tellurium oxide and a silver oxide; a secondary component which includes at least one selected from the group consisting of BaO, WO3 and P2O5; and an additional component which includes at least one selected from the group consisting of oxides of elements in Group 13 of periodic table. A total component of the principal component is 85 mole percent or more in terms of V2O5, TeO2 and Ag2O. Contents of TeO2 and Ag2O each is 1 to 2 times as much as a content of V2O5. A content of the secondary component is 0 to 13 mole percent. A content of the additional component is 0.1 to 3.0 mole percent.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: June 6, 2017
    Assignee: Hitachi Chemical Co. , Ltd.
    Inventors: Takashi Naito, Shinichi Tachizono, Kei Yoshimura, Yuji Hashiba, Takuya Aoyagi, Taigo Onodera, Tatsuya Miyake
  • Patent number: 9608143
    Abstract: The composition for forming an n-type diffusion layer in accordance with the present invention contains a glass powder and a dispersion medium, in which the glass powder includes an donor element and a total amount of the life time killer element in the glass powder is 1000 ppm or less. An n-type diffusion layer and a photovoltaic cell having an n-type diffusion layer are prepared by applying the composition for forming an n-type diffusion layer, followed by a thermal diffusion treatment.
    Type: Grant
    Filed: November 10, 2013
    Date of Patent: March 28, 2017
    Assignee: Hitachi Chemical Co., Ltd.
    Inventors: Youichi Machii, Masato Yoshida, Takeshi Nojiri, Kaoru Okaniwa, Mitsunori Iwamuro, Shuichiro Adachi, Tetsuya Sato, Keiko Kizawa
  • Patent number: 9601679
    Abstract: In a configuration to join thermoelectric elements with an electrode in a thermoelectric module, reduction in junction reliability between the thermoelectric elements and the electrode is suppressed in a high-temperature environment and in an environment in which vibration and shock are imposed as load, to efficiently transmit the outer-circumferential temperature to the thermoelectric elements. In a thermoelectric module in which a plurality of p-type thermoelectric elements and a plurality of n-type thermoelectric element are alternately arranged by aligning the surfaces thereof on the high-temperature side and the surfaces thereof on the low-temperature side, to electrically connect the thermoelectric elements in series to each other; the p-type thermoelectric elements and the n-type thermoelectric element are joined via an intermediate layer with a deformable stress relaxation electrode, to thereby absorb stress taking place during the module assembling process and the module operation by the electrode.
    Type: Grant
    Filed: April 9, 2014
    Date of Patent: March 21, 2017
    Assignee: Hitachi Chemical Co., Ltd.
    Inventors: Tomotake Tohei, Shinichi Fujiwara, Zenzo Ishijima, Takahiro Jinushi
  • Publication number: 20170038324
    Abstract: A permeability evaluation method for evaluating permeability of heavy metal ions through a specimen, comprising a step of, in a state in which a first liquid containing heavy metal ions and a second liquid containing water and an organic solvent are separated by a specimen, applying a voltage between a positive electrode provided on the side of the first liquid and a negative electrode provided on the side of the second liquid and measuring the value of the current flowing between the positive electrode and the negative electrode, wherein the specimen contains an insulating material used in semiconductor production, and the heavy metal ion concentration of the first liquid is 0.5 mg/kg or more.
    Type: Application
    Filed: April 15, 2014
    Publication date: February 9, 2017
    Applicant: Hitachi Chemical Co., Ltd.
    Inventors: Koji SUZUMURA, Kazuhiro YAMAMOTO, Tomoko MURAHASHI
  • Patent number: 9564337
    Abstract: Provided is a polishing liquid including cerium oxide particles, an organic acid A, a polymer compound B having a carboxyl acid group or a carboxylate group, and water, wherein the organic acid A has at least one group selected from the group consisting of —COOM group, -Ph-OM group, —SO3M group and —PO3M2 group, pKa of the organic acid A is less than 9, a content of the organic acid A is 0.001 to 1 mass % with respect to the total mass of the polishing liquid, and a content of the polymer compound B is 0.01 to 0.50 mass % with respect to the total mass of the polishing liquid, and pH is in the range of 4.0 to 7.0.
    Type: Grant
    Filed: December 22, 2011
    Date of Patent: February 7, 2017
    Assignee: HITACHI CHEMICAL CO., LTD.
    Inventors: Munehiro Oota, Takaaki Tanaka, Toshio Takizawa, Shigeru Yoshikawa, Takaaki Matsumoto, Takahiro Yoshikawa, Takashi Shinoda
  • Patent number: 9520529
    Abstract: The composition for forming a composition for forming a p-type diffusion layer, the composition containing a glass powder and a dispersion medium, in which the glass powder includes an acceptor element and a total amount of a life time killer element in the glass powder is 1000 ppm or less. A p-type diffusion layer and a photovoltaic cell having a p-type diffusion layer are prepared by applying the composition for forming a p-type diffusion layer, followed by a thermal diffusion treatment.
    Type: Grant
    Filed: November 9, 2013
    Date of Patent: December 13, 2016
    Assignee: Hitachi Chemical Co., Ltd.
    Inventors: Yoichi Machii, Masato Yoshida, Takeshi Nojiri, Kaoru Okaniwa, Mitsunori Iwamuro, Shuichiro Adachi, Tetsuya Sato, Keiko Kizawa
  • Patent number: 9150920
    Abstract: Embodiments of the invention relate generally to ex vivo methods of quantifying expression of interferon responsive genes and characterizing an individual's potential responsiveness to interferon administration. Certain embodiments relate to methods to monitor the efficacy of ongoing interferon therapy by evaluating expression of interferon responsive genes before and after interferon administration.
    Type: Grant
    Filed: May 3, 2011
    Date of Patent: October 6, 2015
    Assignees: HITACHI CHEMICAL CO., LTD., HITACHI CHEMICAL COMPANY AMERICA, LTD, THE CLEVELAND CLINIC FOUNDATION
    Inventors: Masato Mitsuhashi, Ernest C. Borden
  • Patent number: 9132611
    Abstract: A resin composition comprising a polyamideimide and a polyfunctional glycidyl compound, the polyamideimide having 2 or more carboxyl groups on at least one end of the molecular chain.
    Type: Grant
    Filed: September 28, 2010
    Date of Patent: September 15, 2015
    Assignee: HITACHI CHEMICAL CO., LTD.
    Inventor: Kazumasa Takeuchi